Skip to content
10-Q

Quarterly Report

NEON THERAPEUTICS, INC.

0001694187-19-000038

← back to feed
Filed
May 13, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Apr 30, 2019 28.33M sh
Current Liabilities Q1 2019 · Mar 31, 2019 $11.46M
Current Liabilities Q1 2019 · Dec 31, 2018 $12.69M
Total Liabilities Q1 2019 · Mar 31, 2019 $18.97M
Total Liabilities Q1 2019 · Dec 31, 2018 $12.84M
Current Assets Q1 2019 · Mar 31, 2019 $83.61M
Current Assets Q1 2019 · Dec 31, 2018 $105.43M
Total Assets Q1 2019 · Mar 31, 2019 $101.04M
Total Assets Q1 2019 · Dec 31, 2018 $114.09M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $52.7M
Cash And Equivalents Q1 2019 · Mar 31, 2018 $44.43M
Capex Q1 2019 · Mar 31, 2018 $1.46M
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$14.93M
Stockholders Equity Q1 2019 · Mar 31, 2018 −$111.72M
Stockholders Equity Q1 2019 · Dec 31, 2017 −$93.57M
Sga Expense Q1 2019 · Mar 31, 2018 $3.6M
Rd Expense Q1 2019 · Mar 31, 2018 $13.16M
Net Income Q1 2019 · Mar 31, 2018 −$16.52M
Operating Income Q1 2019 · Mar 31, 2018 −$16.76M